Quipt Home Medical Corp (QIPT) insider trading
Every open-market stock purchase and sale by Quipt Home Medical Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Patrick Dennis Gamble (VP), $24.7K, 21 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent QIPT insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Mar 16, 2026 | Gregory John Crawford (CEO) | Sold (not open market) | $12.2M |
| Mar 16, 2026 | Gregory John Crawford (CEO) | Sold (not open market) | $4.4M |
| Mar 16, 2026 | Hardik Mehta (CFO) | Sold (not open market) | $3.2M |
| Mar 16, 2026 | Mark Alan Greenberg (Director) | Sold (not open market) | $1.6M |
| Mar 16, 2026 | Hardik Mehta (CFO) | Sold (not open market) | $1.3M |
| Mar 16, 2026 | Kevin A. Carter (Director) | Sold (not open market) | $734K |
| Mar 16, 2026 | Thomas Roehrig (C-suite exec) | Sold (not open market) | $631K |
| Mar 16, 2026 | Mark Alan Greenberg (Director) | Sold (not open market) | $476K |
| Mar 16, 2026 | Gregory John Crawford (CEO) | Sold (not open market) | $470K |
| Mar 16, 2026 | Brian Joseph Wessel (Director) | Sold (not open market) | $427K |
| Mar 16, 2026 | Mark Alan Miles (C-suite exec) | Sold (not open market) | $402K |
| Mar 16, 2026 | Hardik Mehta (CFO) | Sold (not open market) | $376K |
| Mar 16, 2026 | Mark Alan Greenberg (Director) | Sold (not open market) | $376K |
| Mar 16, 2026 | Brian Joseph Wessel (Director) | Sold (not open market) | $374K |
| Mar 16, 2026 | Brian Joseph Wessel (Director) | Sold (not open market) | $361K |
| Mar 16, 2026 | Thomas Roehrig (C-suite exec) | Sold (not open market) | $314K |
| Mar 16, 2026 | David Bachelder (VP) | Sold (not open market) | $250K |
| Mar 16, 2026 | Patrick Dennis Gamble (VP) | Sold (not open market) | $219K |
| Mar 16, 2026 | Mark Alan Miles (C-suite exec) | Sold (not open market) | $188K |
| Mar 16, 2026 | Thomas Roehrig (C-suite exec) | Sold (not open market) | $184K |
| Mar 16, 2026 | David Bachelder (VP) | Sold (not open market) | $184K |
| Mar 16, 2026 | Mark Alan Miles (C-suite exec) | Sold (not open market) | $92.1K |
| Mar 16, 2026 | Patrick Dennis Gamble (VP) | Sold (not open market) | $92.1K |
| Mar 16, 2026 | Gregory John Crawford (CEO) | Sold (not open market) | $82.1K |
| Mar 16, 2026 | David Bachelder (VP) | Sold (not open market) | $80.9K |
Who's trading QIPT
- David Bachelder, VP: other filings, last Mar 16, 2026
- Kevin A. Carter, Director: other filings, last Mar 16, 2026
- Gregory John Crawford, CEO: other filings, last Mar 16, 2026
- Patrick Dennis Gamble, VP: other filings, last Mar 16, 2026
- Mark Alan Greenberg, Director: other filings, last Mar 16, 2026
- Hardik Mehta, CFO: other filings, last Mar 16, 2026
- Mark Alan Miles, C-suite exec: other filings, last Mar 16, 2026
- Thomas Roehrig, C-suite exec: other filings, last Mar 16, 2026
- Brian Joseph Wessel, Director: other filings, last Mar 16, 2026
Get free alerts when an insider at Quipt Home Medical Corp files a new trade →